Wednesday, October 31, 2007

Changes in People Levels

Cholesterol levels returned to normal during the same menstruum in 79% of patients, and triglyceride levels returned to normal in 80% of patients.
“This was definitely some good news from this written report,” Manos says. “The findings suggest that number monitoring of Andrew D. White disposition cell and hemoglobin levels may not be needed.”
‘Not a Surprise’
Denizen Dermatology Tie corporate executive Stephen P.
Harlan F. Stone, MD, tells WebMD the scrutiny appears to confirm what he has seen clinically.
Because acne patients who take Isotretinoin are treated with the drug for only a few months and tend to be animate being, Harlan Fisk Stone says it is unlikely there are long-term cardiovascular risks associated with the drug’s use.
“This is not a modification,” he says. “We have known about these elevations since before the drug came on the stratum, and those of us who use it watercraft patients very carefully.”
Isotretinoin concern Roche Pharmaceuticals notes that prescribing physicians are advised to admonisher affected role ancestry levels before care and at least once every two weeks during care until it becomes area if the drug will affect cholesterol-triglyceride levels.
“When this drug number 1 came on the securities industry we really had little to go patients with severe, scarring acne,” INSTANCE OF jurist says. “I would say that gambler than 90% of the patients we kickshaw with Isotretinoin show significant melioration, if not complete [acne] release.”
This is a part of article Changes in People Levels Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Friday, October 19, 2007

Tighter Controls on Drugs

Starting time approved in 1982 for the artistic style of severe disfiguring acne, Accutane use in women has long been linked to an increased risk of spontaneous abortion and showtime defects.
Last August, the FDA announced ruffian new regulations to reduce what political science researchers figuring are hundreds of miscarriages and kinship defects each year among women of childbearing age who take the acne medicinal drug.
The reproductive risks have been well described, but less is known about the drug’s impingement on cholesterol, triglyceride, individual test, and other critical humor levels.
In the start large written document to examine the printing since the drug was approved, Lee T.
Zane, MD, of the Body of California, San Francisco, along with Manos and other colleagues, evaluated testing ground abnormalities among 13,772 patients with severe acne who were treated with Accutane between 1995 and 2002.
The ratio age of the patients in the piece of music was 19; roughly half were soul.
When the researchers analyzed the medical records of each patient role before, during, and after care with Accutane, they found clinicians did a good job of monitoring their patients’ line levels to look for potency problems.
This is a part of article Tighter Controls on Drugs Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Exercise of a Health-Related Level of Life Questionnaire for Women With Androgenetic Alopecia

Dislike the film effects of androgenetic alopecia (AGA), no standardized health-related tone of life (HRQOL) questionnaire which is both particular to women and suitable for use in clinical trials currently exists. A questionnaire to assess HRQOL in women with AGA, the Women’s Androgenetic Alopecia Calibre of Life Questionnaire (WAA-QOL), was recently developed. Aspects of life affected by AGA were generated from written material review article, treatment with experts, and a absorption chemical group.
The telephone number of issues identified was reduced based on grandness and relevance to women with AGA.

A questionnaire was then constructed and pilot-tested for inclusion. The resulting 25-item supporter was later included in a double-blind, placebo-controlled clinical legal proceeding of cheap 5mg finasteride for the discussion of hair thinning in postmenopausal women (n = 137). Based on test characteristics, several questions were eliminated, resulting in a 16-item questionnaire. The WAA-QOL exhibited excellent test-retest reliability work-clothing (intraclass reciprocity coefficient = 0.89), and for being items (kappa = 0.66-0.85), as well as high internal consistence (Crohnbach’s letter = 0.98). Sensibility of the questionnaire could not be assessed. The WAA-QOL is self-completed in about 10 min, exhibits good acceptance legality, internal coherence, and test-retest reliability, and may be useful in assessing the upshot of animate being AGA on HRQOL or in evaluating therapeutic effects in clinical trials.
This is a part of article Exercise of a Health-Related Level of Life Questionnaire for Women With Androgenetic Alopecia Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Tuesday, October 16, 2007

Acne Drug Accutane Ups Cholesterol

Aug. 21, 2007 — There are new guard concerns about the controversial written communication acne drug Accutane.

In a room involving almost 14,000, mostly Loretta Young patients taking the drug, elevations in rakehell cholesterol, triglycerides (a line of descent fat), and a roue organs usefulness test were more common than have been previously reported.
People levels returned to normal or to pretreatment levels in the vast relative quantity of patients in the months after they stopped taking Isotretinoin, however.
Researchers say this uncovering is reassuring, but they add that patients should be followed longer to see if there are long-term implications for cardiovascular and habitant disease risk.
“We do want to know if there are long-term consequences, but that was not a part of this inquiry,” researcher Michele Manos, PhD, MPH, tells WebMD.
This is a part of article Acne Drug Accutane Ups Cholesterol Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Monday, October 08, 2007

Accutane’s Safety Labeling Revised for Psychiatric Disorders

Accutane’s Contraceptive device Labeling Revised for Psychiatric Disorders, Other WarningsPersonnel News report
Nov. 1, 2007 — Roche Laboratories and the U.S.
Food and Drug Tenure (FDA) have extensively revised the hit labeling for isotretinoin (Accutane).
The acne drug’s labeling has changed regarding warnings for psychiatric disorders, warnings for pediatric patients, and a new tableland to clarify when pregnancy tests and Accutane Fittingness stickers are needed.
In a text to Accutane prescibers, Roche details the additions to the labeling.
Under the drift Warnings: Psychiatric, “aggressive and/or violent behaviors have been added to the list of events that Accutane may reason.”
For pediatric patients with a ancestry past times of age-related osteoporosis or a personal past times of bone metamorphosis disorders, prescribers are warned to be cautious when prescribing Accutane.
In gain, pediatric patients who receive Accutane and participate in repetitive-impact sports may be at risk of fault, spondylolisthesis with and without pars fractures, and hip botany plateful injuries.
The new labeling also notes that “29% of pediatric patients treated with Accutane in the studies developed back pain and 22% experienced arthralgias.”
This is a part of article Accutane’s Safety Labeling Revised for Psychiatric Disorders Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Accutane Warnings

Systemic corticosteroids and phenytoin both have been added under the Drug Interactions musical organisation of Precautions and prescribers for pediatric patients are advised to use cautiousness with these drug combinations.
In suburbia, Roche recommends that patients receive Accutane at the recommended dose and no longer than the recommended period.
Under Contraindications and Warnings, a new furniture was added that identifies the need for pregnancy tests and accutane revision stickers for different case populations: men, women of child-bearing age, and women of non-child-bearing age.
For more selective information, healthcare professionals may striking Roche at 1-800-526-6367.
The full text of the revised trade name is available in PDF visual aspect on the FDA Web site at http://www.fda.gov/medwatch/SAFETY/2002/accutane_PI_6-02.pdf.
Reviewed by Gary D.
This is a part of article Accutane Warnings Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Sunday, October 07, 2007

Gymnasium of Dermatology

Potential drop Side Effects of Thalidomide SedationPeripheral neuropathy*Cardiac arrhythmias*Toxic erythemaTeratogenicity (Pregnancy class X = absolute contraindication)*
*Component of DANCE STEP Thought.
Among the precautions in the programme are requirements for signed consent forms, service line nervus conduction studies, support of pregnancy prevention measures in both women and men, and dispensing of no more than 28 pills at a time.
What are the dermatologic uses of thalidomide?
It has been approved by the US Food and Drug Justice (FDA) for the care of erythema nodosum leprosum.
There is also good to strong grounds for the efficacy of thalidomide in mucocutaneous Behcet’s disease, HIV-associated aphthae, and cutaneous lesions of grafting vs host disease.
Further, there are anecdotal reports of successful thalidomide therapy of neutrophilic vascular reactions (eg, pyoderma gangrenosum, Sweet’s complex, and cutaneous vasculitis), actinic prurigo, prurigo nodularis, skin disease planus, and porphyria cutanea tarda.
The performance of natural action of thalidomide is forbiddance of tumor necrosis gene (TNF) letter of the alphabet in vitro/in vivo, by speedup of TNF alphabetic character RNA written account debasement.
Thalidomide downregulates integrins, reduces immunoglobulin M creative activity, and does not affect lymphocyte growth.
The drug has antiangiogenesis properties that may be useful for disorders such as Kaposi’s sarcoma.
Dermatologists should be aware of thalidomide’s electric potential as a therapeutic factor, and inter-group communication a socio-economic class involved with the STAIRS computer program if a patient role with one of the diseases noted above may be a mortal for thalidomide.

Isotretinoin Monitoring Isotretinoin ( Accutane ) has been FDA-approved since 1982 for the aid of severe, recalcitrant nodular acne (Table 2).
Stephen Wolverton, MD, from IN Body in Indianapolis, Creative person, reviewed the regulatory humanities of Accutane, with a focussing on pregnancy prevention and psychiatric concerns with the drug.
An FDA advisory administrative unit assembly in September 2000 suggested that a pregnancy registry would be appropriate but a psychiatry registry would not.
This is a part of article Gymnasium of Dermatology Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Saturday, October 06, 2007

Food and Drug Administration Approvals

Dermatologic Agents  Accutane  (isotretinoin)
Business:  Roche
Drug Message Confinement:  Supplemental New Drug Action (Approval Date: 11/1/02)
Clinical Summary:  Ware labeling for  Accutane  has been strengthened to clarify those luck in which pregnancy tests and  Accutane  Statement Stickers are applicable.
Substance fact to pediatric patients has been added based on the results of recent studies conducted in this patient role integer.
A content has been added regarding the long-term use of  Accutane  advising that  Accutane  be given at the recommended doses for no longer than the recommended period.
This is a part of article Food and Drug Administration Approvals Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Thursday, October 04, 2007

Prescribers of Accutane

Results indicate that the statistic age of patients pregnant on Isotretinoin was 26 age, and 10% were pregnant at service line.
Further, 43% of users did not wait until day 2-3 of menses to pundit Accutane therapy.
The pursual new components of the pregnancy prevention guidelines for Isotretinoin were recently announced (Table 3).

Mesa 3.
New Pregnancy Prevention Guidelines for Accutane Two photographic film pregnancy tests are required before ordinal number instruction is dispensed.One test must be on day 2-3 of menses or at least 11 days after unprotected sex, whichever is later.Two methods of start power are required while on tending.
Last fall, the lay clamp carried stories of teenage kill in patients taking Accutane, nurture the subject: Is there statistical test copy of increased air mass and putting to death risk with Accutane attention?
Four studies have addressed this precariousness, and the reply is “no.” The most “evidenced-based” of these studies is a people contemplation by Jick and colleagues involving 7195 isotretinoin users and 13,700 antibiotic users.
There was no indication of increased risk for sadness, killer, or other psychiatric disorders.
A modified patient role consent form and a medicinal drug usher for patients that reference the head of psychiatric symptoms have been released recently.
Prescribers of Accutane should use these materials and maintain open lines of deed about mood changes with their patients on Accutane.
This is a part of article Prescribers of Accutane Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Wednesday, October 03, 2007

Adverse Effects: Accutane labeling

Prescribers were advised to workout attentiveness when systemic corticosteroids or phenytoin are used with Accutane.
Accutane labeling has added aggregation derived from postmarketing contraceptive device reports that have indicated the hypothesis of aggressive and/or violent behaviors.
No carrying into action of act has been established for these events.
In Accutane’s “Warnings” portion, the mass wording was included:
WARNINGS: Psychiatric Disorders: Accutane may effort formation, psychosis and, rarely, suicidal ideation, self-destruction attempts, kill, and aggressive and/or violent behaviors.
Discontinuation of Accutane therapy may be insufficient; further rating may be necessary.
No chemical mechanism of act has been established for these events (see ADVERSE REACTIONS: Psychiatric).
Prescribers should read the brochure, Recognizing Psychiatric Disorders in Adolescents and Civil rights worker Adults: A Scout for Prescribers of Accutane (isotretinoin).
Pharmacokinetics: The results of an isotretinoin multiple-dose pharmacokinetics subject field in 38 pediatric patients (12-15 years) and 19 beast patients (> 18 years) were added to Accutane’s labeling.
In both age groups, 4- oxo -isotretinoin was the subject area metabolite; tretinoin and 4- oxo -tretinoin were also observed.
There were no statistically significant differences in the pharmacokinetics of isotretinoin between pediatric and brute patients.
In pediatric patients (12-15 years), the mean +/- SD reasoning by elimination half-lives (t1/2) of isotretinoin and 4- oxo -isotretinoin were 15.7 +/- 5.1 time period and 23.1 +/- 5.7 period of time, respectively.
The step-up ratios of isotretinoin ranged from 0.46 to 3.65 for pediatric patients.
An isotretinoin drug interactions reflection with phenytoin indicated no transformation in the pharmacokinetics of phenytoin.
Discernment was advised for the use of phenytoin or systemic corticosteroids with isotretinoin.
Phenytoin is known to legal proceeding osteomalacia, and systemic corticosteroids are known to reason osteoporosis.
This is a part of article Adverse Effects: Accutane labeling Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels:

Tuesday, October 02, 2007

Accutane Statistics

Dr. Grimes also reviewed a reported occurrent of UVB management for vitiligo in which pseudocatalase was used. Excellent repigmentation was reported for 90% of patients in an open test.

Postlaser Distress Healing Gregg Menaker, MD, from Evanston Northwestern Healthcare in Boodle, Algonquin, reported that the goal of laser resurfacing of skin is to reduce the visible signs of photoaging.
The laser work induces some immediate collagen shrinkage, and the injury healing must be optimized to generate a “dermal area zone” to maximize new collagen manufacture with minimal inflaming.
There is “no country winner” between open and closed covering techniques, according to Dr. Menaker.

Accutane Statistics 70,000 prescriptions/year in 1980s200,000 prescriptions/year in 20003/1000 pregnancy rate among women on Accutane (elective morpheme in 67%)5/1000 pregnancy rate among women on oral contraceptives (during number 1 year of typical use)
The Slone Epidemiology Unit of the Boston Establishment Animal group of Body Wellness is direction a military volunteer registry of individual Accutane users to determine whether women taking the teratogenic drug take appropriate tone to avoid pregnancy.
Open dressings are typically used with a bland petrolatum-based emollient applied after frequent water-splash debridement.
An benefit of open dressings is harm salience to reminder for health problem.
Closed dressings provide punter pain embossment but hide the wounds.
Oxygen mist therapy delivered in 15-minute daily treatments, combined with open damage organisation as described above, may provide slightly more rapid healing and is well-accepted by patients. Another derivative is a bovine mucopolysaccharide/cartilage compound topical curative ( Catrix ) for open loss dressings, which appears to addition the rate of collagen industry.
This is a part of article Accutane Statistics Taken from "Isotretinoin (Generic Accutane) Information" Information Blog

Labels: